Isorhamnetin decreased the expression of HMG-CoA reductase and increased LDL receptors in HepG2 cells

Randa El-Rayyes Manal M. Abbas Razan Obeidat Manal A. Abbas   

Open Access   

Published:  Jan 02, 2023

DOI: 10.7324/JAPS.2023.103374
Abstract

Isorhamnetin is a flavonoid present in many plants. In a previous in vivo study, isorhamnetin lowered the serum cholesterol of rats fed a high-cholesterol diet. However, its mechanism of action was not investigated. In the present work, the mechanism of its hypocholesterolemic effect was studied. The expression of 3-hydroxy-3-methylglutaryl- CoA reductase (HMG-CoA reductase) and low-density lipoprotein receptor (LDLR) genes and proteins was studied in HepG2 liver cancer cell line by polymerase chain reaction, western blot, and indirect enzyme-linked immunosorbent assay as well as its antioxidant activity. isorhamnetin had an IC50 of 100, 53, and 40 μM at 24, 48, and 72 hours, respectively, in HepG2 cells. Isorhamnetin downregulated HMG-CoA reductase gene expression significantly. Also, all tested doses of isorhamnetin downregulated LDLR expression and produced no change in membranous LDLR protein expression. In cell lysate, LDLR was increased by all studied concentrations of isorhamnetin. Isorhamnetin (100 μM) decreased intracellular HMG-CoA reductase compared to vehicle-treated control. Furthermore, isorhamnetin increased superoxide dismutase activity and reduced H2O2 level, due to catalase activity. Isorhamnetin reduced HMG-CoA reductase gene expression and increased total LDLR and exerted pronounced antioxidant action.


Keyword:     Antioxidants 3-methylquercetin receptors LDL Hep G2 3-hydroxy- 3-methylglutaryl-CoA reductase


Citation:

Al-Rayyes R, Abbas MM, Obeidat R, Abbas MA. Isorhamnetin decreased the expression of HMG-CoA reductase and increased LDL receptors in HepG2 cells. J Appl Pharm Sci, 2023. https://doi.org/10.7324/JAPS.2023.103374

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Abbas MM, Kandil Y?, Abbas MA. R-(-)-carvone attenuated doxorubicin induced cardiotoxicity in vivo and potentiated its anticancer toxicity in vitro. Balkan Med J, 2020; 37:98. https://doi.org/10.4274/balkanmedj.galenos.2019.2019.7.117

Attie AD, Seidah NG. Dual regulation of the LDL receptor- some clarity and new questions. Cell Metab, 2005; 1:290-2. https://doi.org/10.1016/j.cmet.2005.04.006

Chi G, Zhong W, Liu Y, Lu G, Lü H, Wang D, Sun F. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses. Inflamm Res, 2016; 65:33-41. https://doi.org/10.1007/s00011-015-0887-9

Cohen DE. Balancing cholesterol synthesis and absorption in the gastrointestinal tract. J Clin Lipidol, 2008; 2:S1-3. https://doi.org/10.1016/j.jacl.2008.01.004

Dong G-Z, Lee J-H, Ki SH, Yang JH, Cho IJ, Kang SH, Zhao RJ, Kim SC, Kim YW. AMPK activation by isorhamnetin protects hepatocytes against oxidative stress and mitochondrial dysfunction. Eur J Pharmacol, 2014; 740:634-40. https://doi.org/10.1016/j.ejphar.2014.06.017

Dong X, Sun G, Luo Y. Protective effect of isorhamnetin on oxidative stress induced by H2O2 in H9C2 cells. Chin Pharmacol Bull, 2015; 31:853-60.

Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 2017; 38:2459-72. https://doi.org/10.1093/eurheartj/ehx144

Gao X, Yanan J, Santhanam RK, Wang Y, Lu Y, Zhang M, Chen H. Garlic flavonoids alleviate H2O2 induced oxidative damage in L02 cells and induced apoptosis in HepG2 cells by Bcl-2/Caspase pathway. J Food Sci, 2021; 86(2):366-75. https://doi.org/10.1111/1750-3841.15599

Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature, 1990; 343:425-30. https://doi.org/10.1038/343425a0

Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol, 2009; 29:431-8. https://doi.org/10.1161/ATVBAHA.108.179564

Grundy SM. The issue of statin safety: where do we stand? Circulation, 2005; 111:3016-9. https://doi.org/10.1161/CIRCULATIONAHA.105.557652

Gu Y, Wang X, Liu F, Zhang J, Zhang X, Liu J, Li S, Wang D, Guan H, Hou D. Total flavonoids of sea buckthorn (Hippophae rhamnoides L.) improve MC903-induced atopic dermatitis-like lesions. J Ethnopharmacol, 2022; 292:115195. https://doi.org/10.1016/j.jep.2022.115195

Hrydziuszko O, Wrona A, Balbus J, Kubica K. Mathematical two-compartment model of human cholesterol transport in application to high blood cholesterol diagnosis and treatment. Electron Notes Theor Comput Sci, 2014; 306:19-30. https://doi.org/10.1016/j.entcs.2014.06.012

Igarashi K, Ohmuma M. Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. Biosci Biotechnol Biochem, 1995; 59:595-601. https://doi.org/10.1271/bbb.59.595

Ishola IO, Osele MO, Chijioke MC, Adeyemi OO. Isorhamnetin enhanced cortico-hippocampal learning and memory capability in mice with scopolamine-induced amnesia: role of antioxidant defense, cholinergic and BDNF signaling. Brain Res, 2019; 1712:188-96. https://doi.org/10.1016/j.brainres.2019.02.017

Jiang S-Y, Li H, Tang J-J, Wang J, Luo J, Liu B, Wang JK, Shi XJ, Cui HW, Tang J, Yang F. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nat Commun, 2018; 9:5138. https://doi.org/10.1038/s41467-018-07590-3

Lee J, Jung E, Lee J, Kim S, Huh S, Kim Y, Kim Y, Byun SY, Kim YS, Park D. Isorhamnetin represses adipogenesis in 3T3-L1 cells. Obesity, 2009; 17:226-32. https://doi.org/10.1038/oby.2008.472

Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 2007; 370:1829-39. https://doi.org/10.1016/S0140-6736(07)61778-4

Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab, 2011; 13:376-88. https://doi.org/10.1016/j.cmet.2011.03.009

Mustafa S, Ijaz MU, ul Ain Q, Afsar T, Almajwal A, Shafique H, Razak S. Isorhamnetin: a flavonoid, attenuated doxorubicin-induced testicular injury via regulation of steroidogenic enzymes and apoptotic signaling gene expression in male rats. Toxicol Res, 2022; 11(3):475-85. https://doi.org/10.1093/toxres/tfac024

Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34:3478-90a. https://doi.org/10.1093/eurheartj/eht273

Pandey S, Roy D, Shukla AK. Measuring surface expression and endocytosis of GPCRs using whole-cell ELISA. Methods Cell Biol, 2019; 149:131-40. https://doi.org/10.1016/bs.mcb.2018.09.014

Razali N, Aziz AA, Lim CY, Junit SM. Investigation into the effects of antioxidant-rich extract of Tamarindus indica leaf on antioxidant enzyme activities, oxidative stress and gene expression profiles in HepG2 cells. Peer J, 2015; 3:e1292. https://doi.org/10.7717/peerj.1292

Reiner Ž. Combined therapy in the treatment of dyslipidemia. Fundam Clin Pharmacol, 2010; 24:19-28. https://doi.org/10.1111/j.1472-8206.2009.00764.x

Runhuan F, Haiyan W. Quantitative proteomic analysis of Isorhamnetin treatment in human liver cancer cells. J Med Plant Res, 2018; 12:77-88. https://doi.org/10.5897/JMPR2018.6561

Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G, Gissi-HF Investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet, 2008; 372:1231-9. https://doi.org/10.1016/S0140-6736(08)61240-4

Vogel RA. PCSK9 inhibition: the next statin? J Am Coll Cardiol, 2012; 59:2354-5. https://doi.org/10.1016/j.jacc.2012.03.011

Wang HH, Garruti G, Liu M, Portincasa P, Wang DQH. Cholesterol and lipoprotein metabolism and atherosclerosis: recent advances in reverse cholesterol transport. Ann Hepatol, 2017; 16:S27-42. https://doi.org/10.5604/01.3001.0010.5495

Wu MS, Chien CC, Chang J, Chen YC. Pro-apoptotic effect of haem oxygenase-1 in human colorectal carcinoma cells via endoplasmic reticular stress. J Cell Mol Med, 2019; 23:5692-704. https://doi.org/10.1111/jcmm.14482

Xiao PT, Liu SY, Kuang YJ, Jiang ZM, Lin Y, Xie ZS, Liu EH. Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia. J Ethnopharmacol, 2021; 264:113380. https://doi.org/10.1016/j.jep.2020.113380

Xu Y, Tang C, Tan S, Duan J, Tian H, Yang Y. Cardioprotective effect of isorhamnetin against myocardial ischemia reperfusion (I/R) injury in isolated rat heart through attenuation of apoptosis. J Cell Mol Med, 2020; 24(11):6253-62. https://doi.org/10.1111/jcmm.15267

Xue Z, Song W, Gao X, Yu W, Hou X, Kou X. Structure identification and evaluation of chemical components from the flos sophorae immaturus for inhibitory effects against HepG2. Curr Top Nutraceutical Res, 2021; 19(4):452. https://doi.org/10.37290/ctnr2641-452X.19:452-457

Yang HX, Zhang M, Long SY, Tuo QH, Tian Y, Chen JX, Zhang CP, Liao DF. Cholesterol in LDL receptor recycling and degradation. Clin Chim Acta, 2020; 500:81-6. https://doi.org/10.1016/j.cca.2019.09.022

Yokozawa T, Kim HY, Cho EJ, Choi JS, Chung HY. Antioxidant effects of isorhamnetin 3, 7-di-O-β-D-glucopyranoside isolated from mustard leaf (Brassica juncea) in rats with streptozotocin-induced diabetes. J Agric Food Chem, 2002; 50:5490-5. https://doi.org/10.1021/jf0202133

Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science, 2009; 325:100-4. https://doi.org/10.1126/science.1168974

Zhang S, Zheng L, Dong D, Xu L, Yin L, Qi Y, Han X, Lin Y, Liu K, Peng J. Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem, 2013; 141:2108-16. https://doi.org/10.1016/j.foodchem.2013.05.019

Zhao Z, Liu Y. Cardiovascular protective effect of isorhamnetin. Med Recapitulate, 2008; 14:2321-3.

Zhao J-J, Song J-Q, Pan S-Y, Wang K. Treatment with isorhamnetin protects the brain against ischemic injury in mice. Neurochemi Res, 2016; 41:1939-48. https://doi.org/10.1007/s11064-016-1904-2

Zhou JL, Fang XY, Wang JQ, Zhao LG, Li Y, Tang F, Yue YD. Structures and bioactivities of seven flavonoids from Osmanthus fragrans 'Jinqiu'essential oil extraction residues. Nat Prod Res, 2018; 32(5):588-91. https://doi.org/10.1080/14786419.2017.1318387

Article Metrics

0 Absract views 1 PDF Downloads 1 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required